Europe Sees AI-Driven Cloud Growth in Q4 as Managed Services Demand Slows: ISG Index™
20.1.2025 10:00:00 CET | Business Wire | Press release
Combined market ACV up 17% from prior year, but down 7% from Q3Managed services ACV off 5%, while XaaS soars 42%
AI-driven demand for cloud services fueled overall growth in Europe’s IT and business services market in the fourth quarter, even as demand for managed services slowed, according to the latest state-of-the-industry report from Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm.
The EMEA ISG Index™, which measures commercial outsourcing contracts with annual contract value (ACV) of US $5 million or more, shows ACV for the combined market (both managed services and cloud-based as-a-service) advanced 17 percent, to US $8.3 billion, in the fourth quarter, but slowed by 7 percent sequentially from a record third quarter.
“Europe came off a record high demand for managed services in the third quarter, as continued economic uncertainty and geopolitical tensions weighed on the market during the fourth quarter,” said Steve Hall, president, ISG EMEA. “On the plus side, demand for cloud services surged to an all-time quarterly high, as enterprises reaccelerated their move to the cloud, seeking overall cost savings and greater efficiency and innovation through AI.”
Q4 Results by Segment
Managed services ACV for the fourth quarter declined 5 percent year on year, to US $3.7 billion, and was down 25 percent sequentially from a record third quarter. There were 283 managed services contracts awarded in the quarter, up 10 percent versus the prior year, but down 8 percent quarter on quarter. During the fourth quarter, only one mega-deal (contract with an annual value of $100 million or more) was awarded, down sharply from the six mega deals awarded in Q3. At the other end of the spectrum, deals in the US $5 million to US $9 million category, the smallest measured by the ISG Index, rose 12 percent versus the prior year.
Within managed services, IT outsourcing (ITO) slumped 7 percent year on year, to US $2.7 billion, driven lower by an 18 percent decline in application and development services, the largest ITO segment. Business process outsourcing (BPO), meanwhile, rose 2 percent, to US $992 million, boosted by facilities management and HR services.
ACV in the cloud-based as-a-service (XaaS) segment soared 42 percent versus the prior year, to US $4.6 billion, and was up 14 percent against the prior quarter. The market’s percentage growth year on year was the most in a quarter since the second quarter of 2022. Over the last four quarters, Europe’s demand for cloud services has grown an average of 23.5 percent a quarter.
Both the infrastructure-as-a-service (IaaS) and software-as-a-service (SaaS) segments turned in strong performances in Q4. IaaS climbed 52 percent year on year, to US $3.4 billion, while SaaS rose 21 percent, to $1.2 billion.
Full-Year Results
Combined market ACV was up 14 percent for the full year, to a record US $32.6 billion, surpassing the previous annual record in 2022 by 8 percent. In 2023, the combined market was down 5 percent.
Managed services had a record year, with ACV of US $16.6 billion, up 5.6 percent, although the entire upside for the year was driven by strong growth in Q3. ITO, at US $12.4 billion, was up 6 percent, while BPO, at US $4.1 billion, was up 4 percent. A total of 1,164 managed services contracts were awarded in 2024, up 11 percent from the prior year. Thirteen of those were mega deals, up from 12 in the prior year, even as the combined annual value of the mega deals was down 12 percent.
New scope ACV advanced 10 percent, to a record $10.7 billion. By industry, travel and transportation ACV soared 84 percent versus the prior year, on the strength of large awards in Germany. Energy, retail and manufacturing were each up slightly, while the region’s largest sourcing sector, banking, financial services and insurance (BFSI), slumped 22 percent.
The XaaS market generated ACV of US $16.0 billion, up 23 percent, surpassing its previous annual high in 2022 by 9 percent, after slumping 11.5 percent in 2023. IaaS jumped 30 percent, to US $11.6 billion, while SaaS rose 8 percent, to US $4.4 billion. XaaS accounted for 49 percent of the combined market in 2024, up from 45 percent in 2023.
Geographic Performance
In the fourth quarter, the region’s largest market, the U.K., declined 33 percent from the prior year, to US $935 million of managed services ACV, its weakest quarter in two years after producing seven straight quarters with ACV of more than US $1 billion. Meanwhile, DACH, the region’s second-largest market, saw its ACV rise by 4 percent, to US $719 million, while number-three market France declined 11.5 percent, to US $708 million.
For the full year, the U.K. generated US $4.4 billion of managed services ACV, off 23 percent. DACH came in at $4.3 billion, up 64 percent, buoyed by several large contracts. The Nordics advanced 12 percent, to US $1.6 billion, and the Benelux market finished up 16 percent, to US $1.4 billion. France, meanwhile, was off 5 percent, to US $2.1 billion.
2025 Global Forecast
For the full year, ISG is forecasting 4.5 percent revenue growth for managed services, up from 1.8 percent growth in 2024, and 18 percent revenue growth for XaaS, in line with the prior year.
“We expect a gradual recovery in enterprise demand for IT and business services,” Hall said. “Companies are still cautious amid continuing economic and geopolitical uncertainty. In Europe, we are likely to see subdued growth, with the upcoming elections in Germany creating uncertainty in the market until the second half.
“At the same time, we see some tailwinds at play that should boost the global market,” Hall said. “AI spending continues to gain momentum, with hundreds of billions being spent on infrastructure, setting the stage for widespread adoption. In managed services, we're seeing early signs of improvement in the BFSI sector as discretionary spending begins to pick up.”
About the ISG Index™
The ISG Index™ is recognized as the authoritative source for marketplace intelligence on the global technology and business services industry. For 89 consecutive quarters, it has detailed the latest industry data and trends for financial analysts, enterprise buyers, software and service providers, law firms, universities and the media.
The 4Q24 Global ISG Index results were presented during a webcast January 16. To view a replay of the webcast and download presentation slides, visit this webpage.
About ISG
ISG (Information Services Group) (Nasdaq: III) is a leading global technology research and advisory firm. A trusted business partner to more than 900 clients, including more than 75 of the world’s top 100 enterprises, ISG is committed to helping corporations, public sector organizations, and service and technology providers achieve operational excellence and faster growth. The firm specializes in digital transformation services, including AI, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. Founded in 2006, and based in Stamford, Conn., ISG employs more than 1,600 digital-ready professionals operating in more than 20 countries—a global team known for its innovative thinking, market influence, deep industry and technology expertise, and world-class research and analytical capabilities based on the industry’s most comprehensive marketplace data. For more information, visit www.isg-one.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250120758250/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom